Risk of Bleeding with Non-aspirin Non-steroidal Anti-inflammatory Drugs Before Spine Procedures

  • Registration Closed

Myth: All oral non-aspirin non-steroidal anti-inflammatory drugs (NANSAIDs) are associated with the same risk of a bleeding complication when taken before spinal injection procedures. Learn about the facts surrounding this myth and the best practices to support safe performance of interventional pain procedures in your practice.

Each participant will read the FactFinder and will answer post-test questions to earn continuing medical education (CME) credits.

Authors
Zachary McCormick, MD; Adrian Popescu, MD; and Clark C. Smith, MD, MPH on behalf of the Patient Safety Committee of the Spine Intervention Society.

Copyright
Materials presented in this activity have been made available by the Spine Intervention Society for educational purposes only. We reserve all rights to such material.

Educational Objectives 
Upon completion of this activity, participants should be able to:

  • Identify best practices to ensure patient safety during interventional spine procedures
  • Cite the evidentiary basis for risk mitigation strategies in the safe performance of interventional pain procedures

Author Disclosures Information
RELEVANT FINANCIAL RELATIONSHIPS WITH ACCME DEFINED COMMERCIAL INTERESTS
Zachary McCormick, MD
Nothing to disclose

Adrian Popescu, MD
Nothing to disclose

Clark C. Smith, MD, MPH
Nothing to disclose

OTHER DISCLOSURES
Zachary McCormick, MD
Grant support: SIS, Foundation of PM&R, Midwest Pain Society
Travel expenses: SIS

Adrian Popescu, MD
Travel expenses: SIS

Clark C. Smith, MD, MPH
Nothing to disclose

Accreditation Statement
The Spine Intervention Society (SIS) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation Statement
SIS designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Date of Activity Release: 
6/7/2018
Date of Activity Expiration: 6/6/2021

Components visible upon registration.